my community channelRegister to store your favourite programmes, receive schedule alerts, sign up for factsheets, participate in forums and much more... What's On
 |
Home  Your Charity Space
|
||||||||||||||||||||||||||||||||||||||
my community channelRegister to store your favourite programmes, receive schedule alerts, sign up for factsheets, participate in forums and much more... What's On
|
Home Your Charity Space
|
||||||||||||||||||||||||||||||||||||||
Could multiple sclerosis patients be spared the needle? A team from the Hebrew University of Jerusalem thinks it's possible. The team, headed by Prof. Elka Touitou, has developed a way to transmit medications to the brain through the nose. This breakthrough could change the way drugs to treat MS, an incurable disease, are administered, addressing a potential market worth $6 billion a year.
